# Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia

> **NCT06422650** · PHASE2 · RECRUITING · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 84 (estimated)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** Nigella Sativa capsule 500mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06422650
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-24
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06422650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06422650, "Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06422650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*